citalopram and moclobemide

citalopram has been researched along with moclobemide in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (18.52)	18.2507
2000's	10 (37.04)	29.6817
2010's	11 (40.74)	24.3611
2020's	1 (3.70)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Sen, S; Sinha, N	1
Andreasson, T; Mattsson, C; Sonesson, C; Waters, N	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Neuvonen, PJ; Pohjola-Sintonen, S; Tacke, U; Vuori, E	1
Fischer, P	1
Stein, MB	1
Meyers, BS	1
Clemente, F; Costa, J; Gumà, M; Segura, A	1
Benijts, TH; Dams, R; De Leenheer, AP; Lambert, WE; Van Bocxlaer, JF; Van Peteghem, C; Van Varenbergh, D	1
Atmaca, M; Kuloglu, M; Tezcan, E; Unal, A	1
Chojnacka-Wójcik, E; Kłodzińska, A; Stachowicz, K; Tatarczyńska, E	1
Carey, P; Dupont, P; Niehaus, D; Prinsloo, C; Seedat, S; Stein, DJ; Van der Linden, G; Warwick, JM	1
Cassens, S; Neumann, P; Nickel, EA; Quintel, M	1
Chojnacka-Wójcik, E; Nikiforuk, A; Tatarczyńska, E; Wesołowska, A	1
Nikiforuk, A; Wesołowska, A	1
Fisar, Z; Hroudová, J; Raboch, J	1
Niedzielska, E; Nowak, G; Pałucha-Poniewiera, A; Pilc, A; Pomierny, B; Pomierny-Chamioło, L; Siwek, A	1
Poleszak, E; Serefko, A; Wlaź, P; Wróbel, A	1
Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N	1
Beaulieu, JM; Chahine, M; Poulin, H; Thériault, O	1
Doruyter, A; Dupont, P; Jordaan, GP; Lochner, C; Stein, DJ; Warwick, JM	1
Hung, CC; Ko, AM; Ko, YC; Lane, HY; Lee, CH; Lee, CP	1

Reviews

3 review(s) available for citalopram and moclobemide

Article	Year
Medication treatments for panic disorder and social phobia. Depression and anxiety, 1998, Volume: 7, Issue:3 Topics: Antidepressive Agents, Tricyclic; Benzamides; Benzodiazepines; Citalopram; Clinical Trials as Topic; Clomipramine; Clonazepam; Dose-Response Relationship, Drug; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Piperidines; Recurrence; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders	1998
Depression and dementia: comorbidities, identification, and treatment. Journal of geriatric psychiatry and neurology, 1998,Winter, Volume: 11, Issue:4 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline	1998
[The serotoninergic syndrome: moclobemide and citalopram]. Medicina clinica, 1999, Nov-20, Volume: 113, Issue:17 Topics: Adult; Citalopram; Drug Interactions; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	1999

Trials

2 trial(s) available for citalopram and moclobemide

Article	Year
Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings. Human psychopharmacology, 2002, Volume: 17, Issue:8 Topics: Adolescent; Adult; Citalopram; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Phobic Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	2002
Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial. Epidemiology and psychiatric sciences, 2020, May-06, Volume: 29 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Areca; Asian People; Citalopram; Double-Blind Method; Humans; Intention to Treat Analysis; Male; Mastication; Middle Aged; Moclobemide; Substance-Related Disorders; Treatment Outcome	2020

Article

Year

Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings.

Human psychopharmacology, 2002, Volume: 17, Issue:8

Topics: Adolescent; Adult; Citalopram; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Phobic Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors

2002

Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial.

Epidemiology and psychiatric sciences, 2020, May-06, Volume: 29

Topics: Adolescent; Adult; Aged; Antidepressive Agents; Areca; Asian People; Citalopram; Double-Blind Method; Humans; Intention to Treat Analysis; Male; Mastication; Middle Aged; Moclobemide; Substance-Related Disorders; Treatment Outcome

2020

Other Studies

22 other study(ies) available for citalopram and moclobemide

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship	2011
Systematic in vivo screening of a series of 1-propyl-4-arylpiperidines against dopaminergic and serotonergic properties in rat brain: a scaffold-jumping approach. Journal of medicinal chemistry, 2012, Nov-26, Volume: 55, Issue:22 Topics: Animals; Behavior, Animal; Brain; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Locomotion; Molecular Structure; Psychotic Disorders; Rats; Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses. Lancet (London, England), 1993, Dec-04, Volume: 342, Issue:8884 Topics: Adult; Benzamides; Citalopram; Clomipramine; Drug Interactions; Drug Overdose; Fatal Outcome; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Serotonin	1993
Serotonin syndrome in the elderly after antidepressive monotherapy. Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:6 Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Benzamides; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Psychoses, Substance-Induced; Selective Serotonin Reuptake Inhibitors; Syndrome	1995
A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication. Journal of analytical toxicology, 2001, Volume: 25, Issue:2 Topics: Adult; Antidepressive Agents; Chromatography, High Pressure Liquid; Citalopram; Drug Combinations; Enzyme Multiplied Immunoassay Technique; Fatal Outcome; Gas Chromatography-Mass Spectrometry; Humans; Male; Moclobemide; Radioimmunoassay; Serotonin Syndrome; Suicide	2001
Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test. European journal of pharmacology, 2004, Mar-08, Volume: 487, Issue:1-3 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Depression; Desipramine; Imipramine; Male; Moclobemide; Monoamine Oxidase Inhibitors; Oxadiazoles; Piperazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Swimming	2004
A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder. Metabolic brain disease, 2006, Volume: 21, Issue:2-3 Topics: Adult; Agoraphobia; Antidepressive Agents; Brain; Cerebrovascular Circulation; Citalopram; Female; Humans; Male; Moclobemide; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Space Perception; Tomography, Emission-Computed, Single-Photon	2006
[The serotonin syndrome. Fatal course of intoxication with citalopram and moclobemide]. Der Anaesthesist, 2006, Volume: 55, Issue:11 Topics: Adult; Citalopram; Electrocardiography; Emergency Medical Services; Fatal Outcome; Female; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Suicide	2006
Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. European journal of pharmacology, 2007, Jan-19, Volume: 555, Issue:1 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Citalopram; Desipramine; Drug Interactions; Imipramine; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Phenols; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulfonamides; Swimming	2007
The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats. European journal of pharmacology, 2008, Mar-17, Volume: 582, Issue:1-3 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Bupropion; Citalopram; Dopamine Uptake Inhibitors; Drug Synergism; Imipramine; Injections, Intraperitoneal; Male; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulfonamides	2008
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuro endocrinology letters, 2010, Volume: 31, Issue:5 Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride	2010
Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors. Neuropharmacology, 2014, Volume: 84 Topics: Animals; Antidepressive Agents; Blotting, Western; Brain; Cerebral Cortex; Citalopram; Excitatory Amino Acid Antagonists; Hippocampus; Imipramine; Male; Moclobemide; Morpholines; Pyridines; Radioligand Assay; Rats, Wistar; Reboxetine; Receptor, Metabotropic Glutamate 5; Thiazoles; Tritium	2014
The depressogenic-like effect of acute and chronic treatment with dexamethasone and its influence on the activity of antidepressant drugs in the forced swim test in adult mice. Progress in neuro-psychopharmacology & biological psychiatry, 2014, Oct-03, Volume: 54 Topics: Amitriptyline; Animals; Antidepressive Agents; Citalopram; Depression; Dexamethasone; Dose-Response Relationship, Drug; Glucocorticoids; Imipramine; Male; Mianserin; Mice; Moclobemide; Motor Activity; Neuropsychological Tests; Swimming; Thiazepines	2014
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of affective disorders, 2015, Jul-15, Volume: 180 Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs. European journal of pharmacology, 2015, Oct-05, Volume: 764 Topics: Analgesics; Antidepressive Agents; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; HEK293 Cells; Humans; Membrane Potentials; Moclobemide; Monoamine Oxidase Inhibitors; NAV1.7 Voltage-Gated Sodium Channel; NAV1.8 Voltage-Gated Sodium Channel; Paroxetine; Patch-Clamp Techniques; Selective Serotonin Reuptake Inhibitors; Sodium Channel Blockers; Time Factors; Transfection	2015
Resting functional connectivity in social anxiety disorder and the effect of pharmacotherapy. Psychiatry research. Neuroimaging, 2016, May-30, Volume: 251 Topics: Adult; Antidepressive Agents; Brain; Citalopram; Emotions; Female; Gyrus Cinguli; Humans; Male; Moclobemide; Neuroimaging; Phobia, Social; Rest; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2016